MedTrace Logo

Tranexamic Acid for Upper Gastrointestinal Bleeding

NCT01713101 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 414

Last updated 2014-05-16

No results posted yet for this study

Summary

This study is to see whether the early intravenous administration of tranexamic acid improves the outcome of acute upper gastrointestinal bleeding.

Conditions

  • Acute Upper Gastrointestinal Hemorrhage

Interventions

DRUG

Early intravenous tranexamic acid administration

Initial history taking and physical examination --\> enrollment --\> 1g bolus over 10 minutes followed slow infusion over 8 hours.

DRUG

placebo

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kyuseok Kim, MD · Professor, department of emergency medicine

  • Sang Hyub Lee, MD · Professor, department of internal medicine (gastroenterology)

  • Cheol Min Shin, MD · Professor, department of internal medicine (gastroenterology)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-07-31
Completion
2015-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01713101 on ClinicalTrials.gov